Banner - NPPA Connect

Opinion|Videos|January 13, 2025

Advancements in Laser Safety and Precision for Diverse Skin Types

Author(s)Cheryl Burgess, MD

A panelist discusses how advances in laser technology have improved safety protocols and treatment precision for patients across diverse skin tones, enabling more inclusive and effective cosmetic procedures.

Episodes in this series

1 KOL is featured in this series.

EP. 1 Choosing Effective Laser Devices for Improving Skin Tone and Texture

1 KOL is featured in this series.

EP. 2 Comparing Fractional and Non-Fractional Lasers for Skin Rejuvenation

1 KOL is featured in this series.

EP. 3 Deciding When to Use Combination Therapies With Lasers

1 KOL is featured in this series.

EP. 4 Advancements in Laser Safety and Precision for Diverse Skin Types

1 KOL is featured in this series.

EP. 5 Challenges of Rapid Advancements in Laser Technology

1 KOL is featured in this series.

EP. 6 Expanding Laser Benefits for Diverse Patient Populations

EP. 7 Advancing Care With Laser and Light-Based Technology in Dermatology

EP. 7 Advancing Care With Laser and Light-Based Technology in Dermatology

EP. 8 Adjusting Laser Therapy Treatment Based on Patient Access, History, and Motivation

EP. 8 Adjusting Laser Therapy Treatment Based on Patient Access, History, and Motivation

EP. 9 Benefits of a Combination Treatment Approach Using Laser Therapy

EP. 9 Benefits of a Combination Treatment Approach Using Laser Therapy

1 expert is featured in this series.

EP. 10 Using Laser Therapy for Varied Skin Types and Stages of Acne

1 expert is featured in this series.

EP. 11 Laser Therapy as an Alternative or Combination Treatment for Acne

1 expert is featured in this series.

EP. 12 Efficacy and Safety of Laser Treatment for Patients With Acne

1 expert is featured in this series.

EP. 13 Integrated Approaches to Treating Rosacea With Lasers

1 expert is featured in this series.

EP. 14 Managing Expectations and Minimizing Laser Complications

1 expert is featured in this series.

EP. 15 Melanocyte Preservation and Future Directions for Laser Technology

1 expert is featured in this series.

EP. 16 Patient Goals and Outcomes for Treating Pigmentary Issues With Laser Therapy

1 expert is featured in this series.

EP. 17 Laser Therapy Protocols in Patients With Melasma and Darker Skin Tones

1 expert is featured in this series.

EP. 18 Tolerability and Postcare Benefits of Laser Therapy for Patients With Pigmentary Disorders

EP. 19 Tailored Laser and Light-Based Therapies for Acne, Skin of Color, and Inflammatory Conditions

EP. 19 Tailored Laser and Light-Based Therapies for Acne, Skin of Color, and Inflammatory Conditions

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related to this article

Pediatric atopic dermatitis

October 19th, 2026

Dupilumab Associated With Lower Atopic March Risk in Pediatric Atopic Dermatitis

A retrospective claims analysis of 2897 matched pairs found hazard ratios of 0.48 to 0.67 for new atopic disease with dupilumab vs systemic corticosteroids in children.

Bitopertin Meets All End Points in Phase 3 APOLLO Trial for EPP

October 19th, 2026

Bitopertin Meets All End Points in Phase 3 APOLLO Trial for EPP

Disc Medicine reports the phase 3 APOLLO trial met all primary and secondary end points, with whole-blood PPIX reduced 41.4% vs placebo and an NDA resubmission planned by end of 2026.

Social Media Mythbusters: Can Castor Oil Really Grow Hair?

October 17th, 2026

Social Media Mythbusters: Can Castor Oil Really Grow Hair?

Castor oil has become a popular social media remedy for thicker, longer hair, but evidence supporting its ability to stimulate hair growth remains limited.

EB06 Phase 2 Vitiligo Study Receives FDA IND Clearance

October 16th, 2026

EB06 Phase 2 Vitiligo Study Receives FDA IND Clearance

The FDA clearance allows Edesa to expand an ongoing placebo-controlled study of the CXCL10 antibody EB06 to US sites, with topline data expected in the fourth quarter of 2027.

$FDA Approves Pritelivir for Refractory Mucocutaneous HSV in Immunocompromised Adults$

October 15th, 2026

FDA Approves Pritelivir for Refractory Mucocutaneous HSV in Immunocompromised Adults

The novel oral helicase-primase inhibitor demonstrated significantly higher rates of complete lesion healing compared with investigator’s choice treatment in the phase 3 PRIOH-1 trial.

EADV 2026: DecisionDx-Melanoma Data Support Risk-Based SLNB Decisions in Cutaneous Melanoma

October 14th, 2026

EADV 2026: DecisionDx-Melanoma Data Support Risk-Based SLNB Decisions in Cutaneous Melanoma

Prospective data suggest DecisionDx-Melanoma may help refine SLNB decisions and identify recurrence risk beyond conventional staging.

Q&A: Falk G. Bechara, MD, on Long-Term Tunnel Control and Structural Damage in HS

October 14th, 2026

Q&A: Falk G. Bechara, MD, on Long-Term Tunnel Control and Structural Damage in HS

Falk G. Bechara, MD, discusses long-term tunnel control, structural damage, and the evolving role of biologics and surgery in HS care.

Galderma to Acquire ZO Skin Health for $1.5 Billion

October 14th, 2026

Galderma to Acquire ZO Skin Health for $1.5 Billion

Galderma has agreed to acquire ZO Skin Health for $1.5 billion, adding the physician-dispensed skincare brand to a portfolio that already includes Cetaphil and Alastin.

Trending on Dermatology Times

Social Media Mythbusters: Can Castor Oil Really Grow Hair?

Bitopertin Meets All End Points in Phase 3 APOLLO Trial for EPP

EADV 2026 Atopic Dermatitis Highlights: Tilrekimig, RAC2 Inhibition, and Level Up Data

FDA Approves Pritelivir for Refractory Mucocutaneous HSV in Immunocompromised Adults

Anti-Inflammatory Effects of GLP-1 Medications in Psoriasis and Obesity